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Summary
A main neurogenic niche in the adult human brain is the
subventricular zone (SVZ). Recent data suggest that the
progenitors that are born in the human SVZ migrate via
the rostral migratory stream (RMS) towards the olfactory
bulb (OB), similar to what has been observed in other
mammals. A subpopulation of astrocytes in the SVZ spe-
cifically expresses an assembly-compromised isoform of
the intermediate filament protein glial fibrillary acidic
protein (GFAP-d). To further define the phenotype of
these GFAP-d expressing cells and to determine whether
these cells are present throughout the human subventric-
ular neurogenic system, we analysed SVZ, RMS and OB
sections of 14 aged brain donors (ages 74-93). GFAP-dwas
expressed in the SVZ along the ventricle, in the RMS and
in the OB. The GFAP-d cells in the SVZ co-expressed the
neural stem cell (NSC) marker nestin and the cell prolifera-
tion markers proliferating cell nuclear antigen (PCNA) and
Mcm2. Furthermore, BrdU retention was found in GFAP-d
positive cells in the SVZ. In the RMS, GFAP-d was
expressed in the glial net surrounding the neuroblasts. In
the OB, GFAP-d positive cells co-expressed PCNA. We also
showed that GFAP-d cells are present in neurosphere cul-
tures that were derived from SVZ precursors, isolated
postmortem from four brain donors (ages 63-91). Taken
together, our findings show that GFAP-d is expressed in
an astrocytic subpopulation in the SVZ, the RMS and the
OB. Importantly, we provide the first evidence that GFAP-
d is specifically expressed in longterm quiescent cells in
the human SVZ, which are reminiscent of NSCs.
Key words: adult neural stem cells; astrocytes; subventric-
ular zone; rostral migratory stream; olfactory bulb; aging
brain.
Introduction
The adult human brain contains two regions where continuous
neurogenesis takes place, i.e. the subventricular zone (SVZ) (Sa-
nai et al., 2004; Quinones-Hinojosa et al., 2006) and the sub-
granular zone in the hippocampal dentate gyrus (Eriksson et al.,
1998; Roy et al., 2000). In particular, the SVZ maintains a level
of plasticity into adulthood and can respond to certain neurolog-
ical conditions, such as stroke and Huntington’s disease, by
increasing the number of neuron forming precursor cells that
can potentially replace damaged neurons. In animal models of
brain trauma, disease and stroke, the SVZ responds by produc-
ing new precursor cells, which migrate to the damaged areas
and form new regionally specific neurons (Parent et al., 2002;
Cooper & Isacson, 2004). In the human brain, a similar response
seems to occur after ischaemia (Macas et al., 2006). The SVZ
can react in this way because it is situated close to the striatum,
which is affected in Parkinson’s disease and Huntington’s dis-
ease and it receives nutrients from the cerebrospinal fluid in the
lateral ventricle (for review, see (Curtis et al., 2007a)). One of
the key questions that remain to be answered is which cells in
the SVZ are responsible for ultimately producing the new cells in
the human SVZ.
The composition of the human SVZ is different from that of
the more studied rodent species because of the presence of a
hypocellular gap between the ependymal layer and the dense
astrocytic ribbon, the latter of which contains the neural precur-
sors (Quinones-Hinojosa et al., 2006). There are indications that
a subpopulation of astrocytes in this ribbon, the neurogenic
astrocytes, proliferate in vivo and behave as multipotent precur-
sor cells in vitro (Sanai et al., 2004), implying that SVZ astrocytes
of the adult human brain indeed are neural stem cells (NSCs).
Within the SVZ, three major cell types exist, one of which is the
neurogenic astrocyte known as B-cell (Doetsch et al., 1997),
which is a slowly proliferating cell that asymmetrically divides to
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form a pool of fast-dividing neural progenitor cells, the C-cells.
Type C-cells in turn differentiate into type A-cells, called neuro-
blasts, which migrate through the rostral migratory stream
(RMS) into the olfactory bulb (OB), where they differentiate into
new interneurons (Curtis et al., 2007b). The existence of an
RMS in the human brain, long thought absent, was recently
described by Curtis et al., (2007b). Recently, we have shown
that NSCs are still present in the SVZ of elderly subjects, includ-
ing cases with neurodegenerative diseases, such as Alzheimer’s
disease (Leonard et al., 2009).
NSCs express certain intermediate filament (IF) proteins, and
some reports claim the specificity of these for labelling NSCs. IFs
are highly versatile cytoskeletal structures that have a major
function in cell signalling and migration (Lepekhin et al., 2001;
Pallari & Eriksson, 2006; Herrmann et al., 2007). One IF
expressed in NSCs is nestin, widely regarded as specific for NSCs
(for review, see (Gilyarov, 2008)), but conflicting reports reveal
nestin expression in both reactive and mature astrocytes (Lin
et al., 1995; Gu et al., 2002). Our laboratory has been inter-
ested in specific IF expression as they relate to NSCs. To this
end, our previous work has revealed that SVZ astrocytes in the
human brain express the IF protein glial fibrillary acidic protein d
(GFAP-d) (Roelofs et al., 2005), one of the seven splice variants
of GFAP (Hol et al., 2003; Quinlan et al., 2007), the main IF
protein in astrocytes (Eng et al., 2000)). Moreover, we recently
have described that GFAP-d is expressed in radial glia and SVZ
progenitors of the human foetal brain (Middeldorp et al.,
2010), substantiating our earlier findings that this specific GFAP
isoform is a marker for NSC. GFAP-d (also named GFAP-e (Niel-
sen et al., 2002)) has a unique 41 amino acid carboxy-terminus.
This unique tail domain endows the protein with several proper-
ties distinct from GFAP-a, which are likely to have important
functional consequences for the IF network formed in the SVZ
astrocytes. Firstly, GFAP-d is an assembly-compromised form of
GFAP (Nielsen et al., 2002; Roelofs et al., 2005; Perng et al.,
2008) and its presence in the IF network changes the composi-
tion of the IF network and its associated proteins, such as
aB-crystallin (Perng et al., 2008). The network can tolerate up
to 10% of the GFAP-d isoform, which is approximately the
amount found in the central nervous system (Perng et al.,
2008). A second property of GFAP-d is its ability to interact with
presenilins (Nielsen et al., 2002), which are essential partners in
the gamma-secretase complex. This complex cleaves the trans-
membrane proteins Notch and amyloid precursor protein (APP)
inside the membrane region and therefore is critical for Notch
and APP signalling (Selkoe & Kopan, 2003). Notch signalling is
required for maintenance of NSC populations in both the devel-
oping and adult brain (Alexson et al., 2006), and Notch1
expression can be found in SVZ astrocytes and neuroblasts in
the adult rodent brain (Givogri et al., 2006). Thirdly and finally,
the induced expression of GFAP-d in vitro results in an increased
phosphorylation of Jnk (Perng et al., 2008). In the developing
brain, Jnk is involved in NSC proliferation (Wang et al., 2007),
migration (Mizuno et al., 2005), and differentiation (Kim et al.,
2007).
Localization of GFAP-d and its ability to modulate signalling
pathways important for NSCs suggest that GFAP-d is expressed
by NSCs in the adult SVZ. Here, we have studied the expression
of GFAP-d in the SVZ, RMS and OB in the adult human brain.
We provide evidence that the GFAP-d expressing cells may
indeed be quiescent adult NSCs, as they are present throughout
the human adult neurogenic system, in a subpopulation of
proliferating astrocytes in the SVZ, and in neurosphere cultures
isolated from postmortem adult human SVZ material.
Results
GFAP-d is robustly expressed in an astrocytic ribbon
of variable width along the full length of the SVZ
We have previously described that GFAP-d is expressed in the
SVZ along several brain structures and subpial layers of the adult
human brain (Roelofs et al., 2005). In the current study, we have
systematically studied its expression pattern throughout the SVZ
of five aged control brains at three standardized locations (see
Fig. 1A, and Experimental procedures). When staining these
three areas for GFAP-d, we observed a band of immunostaining
in the SVZ throughout the three sampled locations. The cells in
this band often had an elongated morphology, parallel to the
ependymal lining of the SVZ. The width of the immunoreactive
band, which ranged from 20 to 200 lm (Fig. 1B), was not con-
stant within the three SVZ areas of one donor and showed also
large variability among donors. We have performed a correla-
tion analysis between the variability and several characteristics
of the donors, such as age, sex, postmortem delay and medica-
tion used, and found no significant correlations. Figure 1C–E
shows a typical example of the strong variability of the thickness
of the band of GFAP-d expressing astrocytes throughout the
SVZ of one donor. The SVZ regions of the same donor stained
for all GFAP isoforms revealed many more GFAP positive cells
and encompassed labelling in the caudate nucleus, SVZ and in
the hypocellular gap (Fig. 1F–H). These data substantiate our
earlier findings that GFAP-d is expressed in a subset of astrocytes
in the SVZ, forming a ribbon. In addition, we provide a first
report on the large variation in the width of the astrocytic ribbon
within and between donors, and in the quantity of GFAP-d posi-
tive cells in the SVZ.
GFAP-d is expressed in immature, proliferative SVZ
astrocytes with stem cell characteristics
To establish the specific phenotype of the cells in the astrocytic
ribbon that express GFAP-d, we applied a double-immunolabel-
ling technique using various astrocyte-specific markers in the
three SVZ areas. Results of confocal analysis are shown in Fig. 2;
images showing anatomical localization are shown in
supplemental Fig. S1. GFAP-d was expressed in a subpopulation
of astrocytes that also expressed the astrocyte marker GFAP-a
(Fig. 2A), as shown by clear co-localization with an antibody
specific for the C-terminus of GFAP. The immature astrocyte
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marker vimentin, an IF protein, also co-localized with GFAP-d
(Fig. 2B). To the contrary, the calcium binding protein S100B,
and the enzyme glutamine synthetase (GS), a marker of fully dif-
ferentiated astrocytes, were not expressed in GFAP-d cells.
S100B was expressed in a distinct cell population in the SVZ
(Fig. 2C), most likely representing more mature niche astrocytes;
expression of GS was only found in cells of the parenchyma and
not in the SVZ (Fig. 2D). GFAP-d was not expressed by postmi-
totic neurons, as was shown by the absence of co-localization
with NeuN (data not shown).
To investigate whether GFAP-d cells in the aged SVZ are NSCs,
we studied the co-expression of GFAP-d with proliferation mark-
ers and markers for NSCs. Results of confocal analysis are shown
in Fig. 3; images showing anatomical localization are shown in
supplemental Fig. S2. We found that all GFAP-d positive cells
also express the proliferation marker proliferating cell nuclear
antigen (PCNA; Fig. 3A), the mitosis marker minichromosome
maintenance complex component 2 (Mcm2; Fig. 3B) and the
transcription factor Sox2 (Fig. 3C). The latter marker showed
staining in both cell nuclei and in cytoplasm, which has been
described before for the human brain (Baer et al., 2007). The
phosphorylated form of the histone H3 protein (pHH3) was not
expressed in GFAP-d positive cells (Fig. 3D), and also no double-
labelling with Ki-67, another proliferation marker, was seen
(Fig. 3E); in fact very few pHH3 and Ki-67 positive cells were
present in the SVZ, which is in agreement with earlier reports
(Kukekov et al., 1999). Attempts to co-localize GFAP-d with
CD133 were unsuccessful in this paraffin-embedded material.
We also studied co-localization with the thymidine analogue
BrdU, which labels dividing cells in the S-phase. In one of the
brains treated with BrdU, many BrdU-positive nuclei were found
in the SVZ near the caudate nucleus, many of which were
(A)
(C) (D) (E)
(F) (G) (H)
(B)
Fig. 1 GFAP-d in the aged human SVZ. (A) Schematic location of SVZ tissue samples as collected from the Netherlands Brain Bank (NBB). SVZ1 was taken out at the
level of the most frontal part of the caudate nucleus; SVZ2 came from the area beneath the cingulate gyrus; SVZ3 contained the most posterior part of the lateral
ventricle. (B) Quantification of the width of the GFAP-d ribbon in frontal sections throughout the SVZ of five different donors. (C–E) Examples of GFAP-d staining
(arrows) throughout the SVZ of a control brain (NBB 07-075). F-H) pan-GFAP staining in the same SVZ areas; staining can be found in the parenchyma (arrows) and
in the SVZ (arrowheads). Scale bars indicate 1 cm in A), 100 lm in C–H); data in (B) are represented as mean values ± SEM, n = 5 measurements per SVZ region;
LV = lateral ventricle; dashed line indicates border of GFAP-d positive ribbon. Picture (A) Courtesy of NBB and photo service Pathology department VUMC, NL.
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GFAP-d-positive (Fig. 3F). Besides the SVZ astrocytes, many
fibres around BrdU positive ependymal cells were GFAP-d posi-
tive. Deeper into the brain parenchyma, BrdU positive nuclei
were scarce. In the second human BrdU case, much less BrdU
labelling was found, and there was a corresponding reduction in
the number of double-positive cells. In the second BrdU case,
the time from BrdU injection to postmortem examination was
protracted compared to the first case. Our data so far demon-
strate that GFAP-d positive cells are proliferative, which is one
indication that these cells are indeed NSCs.
Subsequently, we studied whether the cells co-express mark-
ers for different stages of stem cell differentiation. We observed
considerable co-expression between GFAP-d and nestin (B-cells;
Fig. 3G). However, this pattern was variable throughout the
SVZ; we observed regions with almost complete overlap
between the stainings, as well as locations with minimal overlap.
We also observed that GFAP-d positive cells only rarely
expressed the C-cell marker EGF-R (Fig. 3H) or the A-cell marker
b-III-tubulin (Fig. 3I). Attempts to co-localize GFAP-d with PSA-
NCAM or DCX, using different antibodies (as mentioned in
supplementary Table S1), were unsuccessful.
GFAP-d is expressed in the glial net surrounding the
RMS
In 2007, the first details emerged about the existence of the
RMS in the human brain, although organized differently than in
mice (Curtis et al., 2007b). Furthermore, Alonso et al. showed
GFAP-α
Vimentin
GSS100B
07–075 SVZ3(A) (B)
(C) (D)
07–007 SVZ1
07–046 SVZ3 07–014 SVZ1
Fig. 2 Fluorescent double immunostaining of GFAP-d with astrocyte markers in the SVZ. GFAP-d staining is shown in green, the respective astrocyte markers in
red. (A) GFAP-d is expressed in a subpopulation of GFAP-a positive cells. (B) Vimentin expression was found mainly in the SVZ, in all GFAP-d positive cells. (C) S100B
is expressed throughout the tissue, in the SVZ there is no co-expression with GFAP-d. (D) Glutamine synthetase was expressed only in the parenchyma, not in the
SVZ. Blue staining is Topro staining for cell nuclei; scale bars indicate 5 lm in A and B; 10 lm in C and D; individual NBB numbers of the cases are indicated in the
left bottom corner.
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that astrocytes in the rodent RMS are neurogenic (Alonso et al.,
2008). Therefore, we examined the aged human RMS for the
presence of GFAP-d. Indeed, we found GFAP-d to be highly
expressed throughout the RMS (Fig. 4). In fact, GFAP-d is a very
reliable and robust marker of the RMS in the human brain. In
sagittal sections taken from the RMS, the dorsal and rostral
PCNA MCM2 Sox2 
pHH3 Ki-67 BrdU 
Nestin 
(A) 07–075 SVZ1 (B) 07–007 SVZ1 (C) 07–007 SVZ2 
(D) 07–007 SVZ1 (E) 07–075 SVZ2 (F) Case 1 caudate 
(G) 07–014 SVZ1 (H) 07–046 SVZ1 (I) 07-007 SVZ2 
EGFR Tuj1
Fig. 3 Fluorescent double immunostaining of GFAP-d (green) with proliferation and stem cell markers (red) in the SVZ of different control donors. (A)
proliferating cell nuclear antigen (PCNA) expression is high in the SVZ ; most GFAP-d positive cells express PCNA. (B) Most GFAP-d positive cells are Mcm2 positive.
(C) Sox2 is expressed in nuclei and cytoplasm of GFAP-d positive cells. (D) pHH3 positive cells were extremely rare and did not express GFAP-d. (E) Ki-67 positive
cells could only be found occasionally and were not GFAP-d positive. (F) BrdU labelling was found in many GFAP-d positive cells. (G) In double immunostainings for
nestin and GFAP-d, cells could be found with both proteins and with the single proteins. (H) EGF-R was hardly ever found in GFAP-d expressing cells. (I) Rarely,
single cells could be found expressing GFAP-d and b-III-tubulin. Blue staining is Topro staining for cell nuclei; scale bars indicate 10 lm in all; individual NBB
numbers of the cases are indicated in the left bottom corner.
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limbs of the RMS were visible in a number of sections (Fig. 4A–
C). The dorsal limb of the RMS contained a broad band of GFAP-
d immunoreactive stellate-shaped cells with cell bodies that
were about 8–10 lm in diameter and had many long processes.
Fewer GFAP-d immunoreactive cells were found in the rostral
limb of the RMS. There was large variation in the number of
GFAP-d immunoreactive cells in the RMS within and between
donors.
In frontal sections from the striatum, which we studied for dif-
ferent purposes, the dorsal limb of the RMS was visible. In these
sections, we observed that in double immunostaining of GFAP-d
with PCNA, PCNA was highly expressed in the centre of the
stream of the RMS, whereas GFAP-d positive astrocytes were
predominantly found at the border of this stream (Fig. 4D). No
co-localization was found between GFAP-d and PCNA in the
dorsal limb of the RMS (Fig. 4D).
GFAP-d is expressed in proliferative cells in the
olfactory bulb
The OB and olfactory tract (OT) were also highly enriched in
GFAP-d positive cells (Fig. 5). In the centre of the OT, the GFAP-d
positive cells seemed to be organized in streams. Most GFAP-d
positive cells were however located in the outer layers of the OT
(Fig. 5B). In the OB, GFAP-d positive cells were primarily found in
the olfactory nerve layer and glomerular layer (Fig. 5C and D).
Few cells were also localized within the external plexiform layer
and granule cell layer. Double-labelling of GFAP-d with PCNA in
the OB (Fig. 5E and supplemental Fig. S3E) showed that the
GFAP-d cells were proliferative. As the cells were negative for
b-III-tubulin (Fig. 5F and supplemental Fig. S3F), we conclude
that the GFAP-d positive cells were not neuroblasts. In contrast
to the SVZ, we very rarely observed co-expression of vimentin
and GFAP-d (Fig. 5G and supplemental Fig. S3G).
GFAP-d is expressed in postmortem human adult
neurospheres
To obtain further evidence that GFAP-d is expressed in adult
NSCs, we aimed at determining whether GFAP-d is expressed in
neurospheres derived from the SVZ of human adult brain.
Although the neurosphere assay has some limitations (Reynolds
& Rietze, 2005), it has long been used to assess whether a par-
ticular area of the CNS harbours stem cells. We were able to cul-
ture neurospheres from postmortem adult human material
using a protocol we described recently (Leonard et al., 2009)
(Fig. 6A). We isolated NSCs from each donor that came to
autopsy and this was successful for 80% of the cases. As previ-
ously described, we could obtain neurospheres (Fig. 6A) from
elderly donors with and without neurodegenerative diseases.
(A)
(B)
(D)(C)
Fig. 4 GFAP-d expression in the RMS. (A)
Overview of the RMS (arrows) of case ANW228
from the SVZ to the OT in a sagittal section. Boxed
areas are enlarged in (B) and (C). (D) Fluorescent
immunostaining for proliferating cell nuclear
antigen (red) and GFAP-d (green) (arrows) in a
frontal section of the dorsal limb of the RMS of
case NBB 06-002. Blue staining is Hoechst staining
for cell nuclei. LV = lateral ventricle, CN = caudate
nucleus, FWM = frontal white matter,
RMS = rostral migratory stream, OT = olfactory
tract; scale bars indicate 2 mm in (A), 0.1 mm
in B–D.
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We found that GFAP-d is indeed expressed in proliferative and
multi-potent neurospheres. In all the cultures that we stained
for GFAP-d, we could find immunoreactivity (Fig. 6B–E), overlap-
ping the expression of GFAP-a (Fig. 6B), nestin (Fig. 6C), and
vimentin (Fig. 6D). In the neurospheres, expression of GFAP-d
and the early neuronal marker b-III-tubulin was found mainly in
distinct cell populations (Fig. 6E). Detailed analysis of co-label-
ling using confocal microscopy, showing co-localization with
GFAP-a, nestin and vimentin, but not b-III-tubulin can be found
in supplemental Fig. S4. We confirmed the expression of GFAP-
d at the RNA level by qPCR in different individual neurospheres
from several donors (data not shown). We also found GFAP-d to
be expressed in newly differentiated astrocytes (Fig. 6F). This is
in contrast to our findings in primary astrocyte cultures isolated
from adult human brain, where it was rare to see GFAP-d stain-
ing (unpublished data).
Discussion
In this study, we have shown that GFAP-d expressing cells are
present throughout the aged human SVZ, RMS, OT, and OB. In
the SVZ and OB, GFAP-d is expressed in a subpopulation of pro-
liferative astrocytes that express stem cell and proliferation
markers and retain BrdU longterm; and in the RMS in the glial
net. We also show that GFAP-d positive cells are present in neur-
ospheres isolated from postmortem adult SVZ. Taken together,
(A)
(B) (C) (D)
(E) (F) (G)
Fig. 5 GFAP-d expression in the olfactory bulb and tract. (A) Overview of the olfactory bulb (OB) and part of the olfactory tract (OT) of a control donor (NBB 06-
080), stained for GFAP-d. Boxed areas are enlarged in (B) for the OT and in (C) and (D) for the glomerular layer of the OB. (E) Fluorescent immunostaining of
proliferating cell nuclear antigen (PCNA) (red) and GFAP-d (green) in the glomerular layer of the OB (NBB 05-083). PCNA was expressed throughout the glomerular
layer; co-expression with GFAP-d was observed in many cells. (F) Fluorescent immunostaining of b-III-tubulin (red) and GFAP-d (green) in the glomerular layer of the
OB (NBB 07-014). No co-expression of these proteins was observed. (G) Fluorescent immunostaining of vimentin (red) and GFAP-d (green) in the glomerular layer
of the OB (NBB 05-083). Co-expression of these proteins was only rarely observed. Scale bars indicate 2 mm in (A), 100 lm in B-D, 10 lm in E-F.
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our data provide evidence that GFAP-d expressing cells in the
aged human brain are slow-cycling neurogenic astrocytes and
thus NSCs.
GFAP-d expression was found along the entire length of the
SVZ of the lateral ventricles in a ribbon-like pattern. The width of
this ribbon and the intensity of the expression in the brain mate-
rial studied were variable within cases and between cases. It is
known that there is a variation in hippocampal neurogenesis, of
up to 300%, between different strains of mice, implying that
genetic factors influence neurogenesis considerably (Kemper-
mann et al., 2006). Genetic differences could therefore explain
the variability in the number of NSCs, and thus the number of
GFAP-d cells. Alternatively, growth factors are very important in
stem cell regulation. For instance, VEGF and EGF influence
GFAP-positive cells in the SVZ (Gonzalez-Perez et al., 2009; Mani
et al., 2010). These and other growth factors might influence
the splicing of GFAP in this region. Other than genetics and
growth factors, there are many factors that influence neurogen-
esis (reviewed in (Zhao et al., 2008)), such as age, exercise, nico-
tine and a number of medications. However, the variability we
observed in the GFAP-d ribbon could not be explained by any of
these factors, which were described in the medical files of the
donors.
The cyto-architecture of the human SVZ has been described
before (Quinones-Hinojosa et al., 2006), also with respect to the
GFAP-positive astrocytic ribbon. In part, we observed a similar
pattern for pan-GFAP expression, although we saw more varia-
tion in pan-GFAP staining patterns between donors. In the con-
trol donors we used, we observed a ribbon of GFAP positive cells
directly adjacent to the hypocellular gap. For GFAP-d, we saw a
ribbon of positive cells in the same location as described before
(Roelofs et al., 2005), where fewer cells were stained for GFAP-
d compared to pan-GFAP. Moreover, pan-GFAP expression
could be found throughout the adjacent parenchyma, whereas
GFAP-d staining is almost undetectable in these regions. Our
data suggest that GFAP-d expression is restricted to the subpop-
ulation of neurogenic astrocytes in the astrocytic ribbon of the
SVZ.
We support this view by showing that the GFAP-d expressing
cells in the SVZ are an immature subpopulation of astrocytes
that have clear NSC-like features. These cells expressed the
immature astrocyte marker vimentin, and the general astrocyte
marker GFAP-a (Eng et al., 2000). Furthermore, the GFAP-d
positive cells lacked expression of GS, a marker for fully differen-
tiated astrocytes, and of S100B, which in the rodent is not
present in NSCs, but more mature astrocytes in the SVZ (Raponi
(A) (B)
(C) (D)
(E) (F)
Fig. 6 GFAP-d in neurosphere cultures from post-
mortem human brain. (A) Neurosphere from donor
NBB 08-008 after 15 days in culture. (B)
Neurosphere cryosection from NBB 08-076,
stained for GFAP-d (green) and GFAP-a (red). (C)
Neurosphere cryosection from NBB 08-076,
stained for GFAP-d (green) and nestin (red). (D)
Neurosphere cryosection from NBB 08-078,
stained for GFAP-d (green) and vimentin (red). (E)
Neurosphere cryosection from NBB 08-078,
stained for GFAP-d (green) and b-III-tubulin (red).
(F) Newly differentiated astrocytes stained for pan-
GFAP (red) and GFAP-d (green) 14 days after
differentiation (NBB 08-029). Blue staining is
Hoechst staining for cell nuclei; scale bars indicate
50 lm in B–E, 200 lm in F.
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et al., 2007). Co-localization of GFAP-d with the proliferation
markers PCNA, Mcm2 (Maiorano et al., 2006), and BrdU indi-
cates that these cells are proliferative. Additionally, Sox2, a tran-
scription factor important for the maintenance of NSCs
(Graham et al., 2003), is co-expressed with GFAP-d. The reten-
tion of BrdU in GFAP-d positive cells months after the BrdU injec-
tion suggests that these cells are slow-cycling. For the NSC
marker nestin, we found a variable pattern of double-staining
with GFAP-d, with numerous cells expressing both proteins, but
also cells expressing either of the IF proteins. While nestin is
widely used as a marker for NSCs, previous studies have shown
that expression is not restricted to precursor cells and that there
is little overlap with GFAP staining in the human SVZ (Gu et al.,
2002). We were unable to reproduce this last finding; instead
we saw considerable overlap in staining in certain regions, but
this might be an illustration of the variability one might observe
in nestin-GFAP patterns or a difference in the antibodies that
were used for GFAP. We could not find double-labelling with
the proliferation markers pHH3 and Ki-67, but it must be noted
that only a few cells expressing these proteins could be found,
consistent with previous reports (Kukekov et al., 1999; Quinon-
es-Hinojosa et al., 2006). This might be because of the very tight
regulation of these proteins, i.e. the short half-life of Ki-67
(Mandyam et al., 2007), and the regulation of phosphorylation
of the histone H3 protein (Juan et al., 1998). NSCs are slow-
cycling cells (Doetsch et al., 1997), and therefore it is not surpris-
ing that tightly regulated proliferation markers are only sparsely
observed, or even not observed at all, in the aged human neuro-
genic brain areas. We only rarely observed co-expression
between GFAP-d and EGF-R, a marker for C-cells, and between
GFAP-d and b-III-tubulin, an A-cell marker, substantiating that
the GFAP-d-positive astrocytes are B-cells.
In the RMS, we observed GFAP-d staining mostly in glial cells
surrounding the stream of neuroblasts. The cyto-architecture of
the human RMS differs from the rodent, where there is a typical
GFAP-positive glial tube (Peretto et al., 1997), which is rich in
extracellular matrix components (Thomas et al., 1996). In the
human brain, the neuroblasts in the RMS are surrounded by a
glial ‘net’ or ‘mesh’ (Kam et al., 2009), as in the rabbit (Fasolo
et al., 2002) and adult rhesus monkey brain (Pencea et al.,
2001). The basic structural organization seen in the SVZ is main-
tained in the RMS on the side adherent to the caudate nucleus
and the ependymal structure, whereas limited SVZ components
are maintained on the septal or medial side of the RMS (Kam
et al., 2009). From work in rodents and human material, it is
clear that the RMS itself still contains precursor cells (Gritti et al.,
2002; Alonso et al., 2008; Mendoza-Torreblanca et al., 2008;
Kam et al., 2009), but from recent work, it appears unlikely that
these are GFAP-positive in human adult brain, as no PCNA+ ⁄G-
FAP+ cells were found (Kam et al., 2009), which is in line with
our results for PCNA and GFAP-d in this area. Thus, in the RMS,
GFAP-d is most likely only expressed in cells of the glial net sur-
rounding the migrating neuroblasts.
In the OB, GFAP-d was found mostly in the glomerular layer,
which is one of the regions where neuroblast migration termi-
nates in rodents and where neuronal turnover takes place
throughout life (Bagley et al., 2007). In the human brain, puta-
tive precursor cells were found within several areas of the OB,
among which is the glomerular layer (Liu & Martin, 2003;
Bedard & Parent, 2004). In our experiments in the human OB,
we saw that GFAP-d expressing cells expressed PCNA, indicating
local proliferation of these cells. This makes these cells excellent
candidates for the putative precursor cells described before in
this area.
To investigate GFAP-d in the process of neurogenesis more
in depth, we established postmortem human neurosphere
cultures, which we described recently (Leonard et al., 2009).
In this in vitro model for NSCs, we found GFAP-d expression
at mRNA and protein level. GFAP-d positive cells could be
found throughout the neurospheres, co-expressing GFAP-a,
nestin and vimentin. As in the human adult SVZ, we
observed that GFAP-d and the early neuronal marker b-III-
tubulin were expressed in mostly distinct cell populations.
From these results, we can conclude that GFAP-d is most
likely expressed in neural precursor cells of the adult human
brain, as we have found for the foetal human brain (Middel-
dorp et al., 2010). We are aware of the fact that the ulti-
mate proof is still lacking, as we cannot isolate the GFAP-d
cells specifically to subject them to the neurosphere assay.
For this purpose, we need to find specific cell-surface mark-
ers on GFAP-d cells, enabling us to isolate them through
FACsorting. Another observation from the neurosphere cul-
ture system was that newly differentiated astrocytes highly
expressed GFAP-d, as demonstrated previously (Leonard
et al., 2009), which is not the case in primary astrocytes iso-
lated directly from postmortem human brain. This indicates
that GFAP-d is also an indicator of the differentiation state
of cells.
The fact that NSCs express GFAP-d has important func-
tional implications. Firstly, GFAP-d can destabilize the existing
cytoskeleton of a cell (Nielsen & Jorgensen, 2004; Roelofs
et al., 2005; Perng et al., 2008), which might make a cell
more flexible. This can potentially facilitate proliferation, as it
is known that a cell must retract its processes, before divi-
sion (Coskun et al., 2007). Also, an increased flexibility of
the cytoskeleton is necessary for the migratory capacity of
cells, and GFAP has been shown to have an effect on astro-
cyte motility (Lepekhin et al., 2001). GFAP-d could thus alter
motility of migrating cells as well, by altering the properties
of the cytoskeleton. This is in part supported by the mor-
phology of GFAP-d cells, which are often elongated in a
direction parallel to the ependymal lining of the SVZ.
Another aspect of GFAP-d expression in NSCs is its influence
on cell signalling, as it can modulate Notch (Nielsen et al.,
2002) and Jnk (Perng et al., 2008) signalling. An example of
IF-mediated signalling is the regulation of the apoptosis-
inducing activity of Cdk5 by nestin (Pallari & Eriksson, 2006),
which may be the function of nestin in NSCs. A possible
function of GFAP-d in NSCs might be the modulation of
Notch and ⁄ or Jnk signalling in stem cells.
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In summary, we observed GFAP-d expression in quiescent
NSCs in the adult human SVZ, in cells of the glial net of the RMS,
in precursor cells in the OB, and in newly differentiated astro-
cytes in vitro. These results are based on co-localization studies
with several markers of neurogenesis, which have been vali-
dated extensively in rodents. For humans, results have been
more ambiguous, e.g. for nestin (Gu et al., 2002) and double-
cortin (Verwer et al., 2007). Therefore, all results from human
studies must be interpreted with caution, but we believe that
with the various markers we have used, we can state that GFAP-
d is most likely a marker for NSCs ⁄ B-cells at least in the SVZ. The
presence of GFAP-d in some C- and A-cells and young astrocytes
could represent a transitional stage between the stem cells and
their differentiated progeny. Expression of GFAP-d in the RMS
glial net suggests that it may also be important for the neuro-
genic niche. GFAP-d positive cells in the OB may represent local
precursor cells, but the stem cell pool in this region of the human
brain has not been studied extensively yet.
Understanding the regulation of neurogenic cells is of impor-
tance with regard to neurological disorders where replacement
of neurons is necessary, such as in Alzheimer’s disease, Parkin-
son’s disease, and stroke. The fact that NSCs can be found even
in the aged human brain (Leonard et al., 2009) gives hope that
when the precise regulation of NSCs is understood, endogenous
repair by these cells may be feasible.
Experimental procedures
Postmortem human brain material
Tissue from the SVZ, RMS, and OB was obtained from the Neth-
erlands Brain Bank (NBB; Amsterdam, The Netherlands) and the
department of Anatomy and Neurosciences (ANW), VU Univer-
sity Medical Centre (Amsterdam, The Netherlands). The NBB
and ANW perform brain autopsies with regularly short postmor-
tem intervals, and the brain donors have given informed consent
for using the tissue and for accessing the extensive neuropatho-
logical and clinical information for scientific research, in compli-
ance with ethical and legal guidelines (Huitinga et al., 2008).
Clinico-pathological information of all donors can be found in
Table 1.
SVZ material
SVZ tissue for immunohistochemistry was sampled from three
standardized areas in the brain as depicted in Fig. 1A. SVZ1
was dissected out at the level of the most frontal part of the
caudate nucleus; SVZ2 came from the area beneath the cingu-
late gyrus; SVZ3 contained the most posterior part of the lat-
eral ventricle. In SVZ1, both white and grey matter could be
found aligning the SVZ, while in SVZ2 and SVZ3 only white
matter was seen. The donor brain tissue for this part of our
Table 1 Clinico-pathological data of the brain donors
NBB
number
Area studied Sex Age
(years)
Diagnosis Braak stage
(Tau ⁄ amyloid)
PMD
(h:min)
pH
CSF
Brain
weight (g)
Cause of death
05-019 OB M 74 Nondemented control 3C 05:00 6.70 1125 Bronchus carcinoma
05-061 OB F 93 Nondemented control 2 O 05:50 – 1145 Cachexia
05-065 OB & RMS F 93 Nondemented control 1 A 04:25 7.30 1223 Heart failure
05-083 OB F 85 Nondemented control 1 B 05:00 6.72 1257 Multi organ failure after a
ruptured abdominal
aneurysm
06-080 OB & RMS F 89 Nondemented control 2 B 06:25 6.46 1210 Old age, possible ruptured
abdominal aneurysm
07-007 SVZ & OB M 84 Nondemented control 1 A 05:35 6.98 1457 Heart failure
07-014 SVZ & OB M 86 Nondemented control 2 B 04:00 – 1250 Respiratory insufficiency
07-032 SVZ F 87 Nondemented control 3 O 07:20 6.24 1140 Cachexia and dehydration
07-046 SVZ M 89 Nondemented control 1 B 09:20 6.40 1285 Sudden death
07-075 SVZ F 82 Nondemented control 2 O 05:10 6.64 1210 Pneumonia by hemothorax
06-002 RMS F 84 Parkinson’s disease 2 B 07:25 6.85 1244 Unknown
06-049 RMS F 84 Nondemented control 1 O 04:45 6.26 1179 Heart failure
ANW228 RMS M 91 Nondemented control 2 B <24:00 – – Heart failure
ANW237 RMS M 82 Nondemented control 2 B <24:00 – – Old age, dehydration
08-018 Cultured SVZ F 89 Control with vascular
encephalopathy
4 B 03:30 6.49 1220 Renal insufficiency
08-029 Cultured SVZ M 84 Alzheimer’s disease 6 C 08:05 5.95 1345 Shock by hematemesis
08-076 Cultured SVZ F 91 Depression 3 C 05:20 6.53 1233 Cachexia and dehydration
by pneumonia and renal
insufficiency
08-078 Cultured SVZ M 63 Fronto-temporal dementia 0 O 06:05 6.27 1327 Cachexia and dehydration
by end stage dementia
NBB, Netherlands Brain Bank; SVZ, subventricular zone; RMS, rostral migratory stream; OB, olfactory bulb; M, male; F, female; Braak stage is a scale for
Alzheimer pathology, scoring tau (Braak and Braak, 1991) and amyloid (Thal et al., 2000) pathology; PMD, postmortem delay; CSF, cerebrospinal fluid; pH
CSF indicates the agonal state of the donor (Ravid et al., 1992).
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study was selected using the following criteria: the clinical his-
tory of donors was free from any neurological disease or neu-
ropsychiatric disorder; their brains did not have an Alzheimer
Braak score higher than 3 or significant Parkinson’s disease
pathology. Furthermore, we excluded donors who had recently
used medication that might affect neurogenesis, i.e. anti-mitot-
ics and anti-depressants.
For neurosphere cultures, SVZ tissue was freshly isolated from
the anterior horn of the SVZ. As we were restricted to the mate-
rial that we could obtain from the NBB and the fact that the full
neuropathological report is not available at the starting point of
culturing, we included in this part of the study also patients with
neurological and neuropsychiatric diseases.
BrdU material
Striatal tissue containing the SVZ was used from two donors
who had received BrdU for diagnostic purposes as previously
described (Eriksson et al., 1998). Case 1 was female and
received BrdU 129 days before death. Case 2 was also female
and died 1693 days after BrdU administration.
RMS and OB material
Tissue of the human forebrain comprising the region surround-
ing the anterior horn of the lateral ventricle, frontal part of the
caudate nucleus, gyrus rectus, substantia perforata anterior and
OT, was sampled to study the RMS. Samples of the OT and OB
were collected and processed for immunohistochemistry as well.
The control donors for analysis of the RMS and OB were selected
as for the SVZ. All tissue was immersion-fixed in phosphate-buf-
fered 4% paraformaldehyde (PFA; pH 7.4) for 4 weeks before
processing.
Immunostaining
Immunostaining was performed according to a fairly standard
protocol, described in full in the supplemental data. Briefly, epi-
tope retrieval was performed in a steamer and a serum-blocking
step was used before incubating with antibody (supplementary
Table S1) overnight. The antibodies were visualized using bioti-
nylated secondary antibodies, ABC, and DAB, or fluorescently
labelled secondary antibodies.
Human postmortem neurospheres cultures
Neurosphere cultures were initiated as described previously
(Leonard et al., 2009). The obtained microglia-poor cell pellet
was taken up in serum-free medium (SFM, Neurobasal medium,
1% B27, 0.5% N2, 1% Glutamax, 1% P ⁄ S, Hepes (all Invitro-
gen, Carlsbad, CA, USA), 1% Ultraglutamin (Cambrex Corpora-
tion, East Rutherford, NJ, USA), 5 lg mL)1 heparin (Sigma,
St. Louis, MO, USA), 20 ng mL)1 epidermal growth factor
(EGF), and 20 ng mL)1 fibroblast growth factor (FGF; both
Tebu-Bio, Paris, France) and plated in a 12-well plate. For differ-
entiation, spheres were centrifuged and replated in complete
Dulbecco’s Modified Eagle Medium (DMEM; containing 10%
fetal calf serum, 1% P/S, Hepes; all Invitrogen) on 12-mm poly-
L-lysine-coated glass coverslips.
For quantitative real-time polymerase chain reaction (qPCR),
single neurospheres were isolated and taken up in 100 lL Tri-
zol (Invitrogen). RNA was isolated according to the manufac-
turer’s protocol, with addition of glycogen to facilitate RNA
precipitation. A DNase (Invitrogen) step was used to degrade
genomic DNA contamination. cDNA synthesis and qPCR for
GFAP-d were performed as previously described (Perng et al.,
2008).
For immunostaining, the neurospheres were fixed for 20 min
in 3.7% formaldehyde solution (Sigma) in phosphate-buffered
saline (PBS; 50 mM potassium phosphate, 150 mM NaCl; pH
7.2), after which they were embedded in TissueTek (Bayer, Le-
verkusen, Germany) for cryosectioning and mounted on Super-
frost plus slides. Differentiated cells were fixed with
formaldehyde solution in PBS on coverslips. Then, the 10-lm
thick cryosections or coverslips were washed in TBS and incu-
bated with antibodies (see supplementary Table S1) in TBS-BSA
for 16–24 h at 4C. After three rinses with TBS, secondary anti-
bodies in TBS-BSA were applied for 1 h at RT. Then, the sec-
tions or coverslips were rinsed three times and embedded in
Mowiol.
Image acquisition and analysis
Images of single immunostainings were obtained on an Axio-
Skop microscope (Zeiss, Oberkochen, Germany) with Neoplan-
fluor objectives, using a Sony XC77 black and white camera
(Sony, San Diego, CA, USA) and ImagePro software (MediaCy-
bernetics, Bethesda, MD, USA). Images of immunofluorescent
staining were obtained on an AxioPlan 2 microscope (Zeiss) with
Planapochromat objectives, using an Evolution QEi black and
white camera (MediaCybernetics) and ImagePro software. Con-
focal images were obtained on a Zeiss LSM 510 Meta Confocal
Microscope (Zeiss).
For the quantification of the width of the GFAP-d ribbon,
low magnification images were taken of the whole SVZ
present in one section. In this image, an area of interest
(AOI) was drawn around the SVZ. In this AOI, 5 images
were captured at high magnification in a randomized way.
In the high magnification image, again an AOI was drawn,
this time around the GFAP-d-positive area. The average
width of this AOI was measured and used as the width of
GFAP-d staining.
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Supporting Information
Additional supporting information may be found in the online
version of this article:
Fig. S1 Fluorescent double immunostaining of GFAP-d with
astrocyte markers in the SVZ.
Fig. S2 Fluorescent double immunostaining of GFAP-d (green)
with proliferation and stem cell markers (red) in the SVZ of dif-
ferent control donors.
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Fig. S3 GFAP-d expression in the olfactory bulb and tract.
Fig. S4 Confocal pictures of GFAP-d in neurosphere cultures
from post-mortem human brain.
Table S1 Specifications of the antibodies used.
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